Why TRT Raised Your Blood Pressure (and How to Fix It)

Your blood pressure went up after starting TRT, and the answer most people get is either "that's normal" or "take a blood pressure medication." Neither of those is the real answer, because the blood pressure increase is almost always coming from one of three specific mechanisms, and each one has a direct fix.

To understand why, you need to understand what testosterone is actually doing to your body at a system level. When you introduce exogenous testosterone, your body responds to it across multiple systems at once. It increases red blood cell production. It increases conversion to estrogen through a process called aromatization. And it increases total blood volume. All three of those changes put pressure on your cardiovascular system in different ways, and if none of them are managed, your blood pressure climbs. If all three are managed, the picture actually reverses, and we'll come back to that at the end.

Start with red blood cells, because this is the biggest driver for most men.

Your kidneys produce something called erythropoietin, which is a hormone that signals your bone marrow to make more red blood cells. Testosterone amplifies that signal. The more testosterone you take, the more your kidneys push on that signal, and the more red blood cells your body makes. A 2008 study published in the Journal of Clinical Endocrinology and Metabolism confirmed this relationship is linear and dose-dependent, meaning the effect scales directly with the dose.

The problem with more red blood cells is what it does to your blood's physical properties. Think of blood like a river carrying sediment. The more sediment in the water, the thicker the water becomes, and the harder the current has to work to push it through the same channel. Your heart is that current. When blood gets thicker, your heart has to generate more pressure to move it, and that pressure shows up in your numbers.

The clinical data makes this concrete. A 2024 randomized controlled trial measured blood pressure in men receiving testosterone therapy versus placebo and found that the testosterone group saw their systolic blood pressure rise 6.2 mmHg while the placebo group actually dropped 7 mmHg, a net difference of 13.2 mmHg between groups. But the more important finding was what happened inside the testosterone group. The men whose hematocrit, which is the percentage of your blood made up of red blood cells, rose more than 6 percentage points drove most of that difference. Hematocrit is the number you need to watch, and the threshold that requires action is 54%. Above that level, the evidence supports reducing the dose or, in some cases, pausing therapy entirely.

The second mechanism is estrogen, and this is where a lot of clinics create a problem while trying to solve one.

Your body converts testosterone into estradiol through a process called aromatization, which happens primarily in fat tissue. When your estradiol climbs too high, it causes your kidneys to retain more sodium and water, and that extra fluid volume increases the pressure inside your vessels. A 2005 study tracking men on testosterone therapy showed that testosterone independently increased extracellular water through direct effects on the renal tubules, which are the filtration structures in the kidney. More fluid in the wrong compartments means higher pressure.

The instinct is to block the conversion. Aromatase inhibitors, which are drugs that block the enzyme responsible for converting testosterone to estrogen, are often prescribed to control estradiol. And they do control it. Sometimes too well.

When estradiol is suppressed too far, blood pressure can actually go up from the opposite direction, because estradiol is cardiovascular protective. It helps keep blood vessels flexible and responsive. Animal research published in the American Journal of Physiology showed that blocking aromatase increased mean arterial pressure even when testosterone wasn't in the picture, meaning the low estrogen itself was driving the problem. So if you are on an aromatase inhibitor and your blood pressure is still elevated, your estradiol may be too low rather than too high.

The target range for sensitive estradiol is 20 to 40 pg/mL. The way to stay in that range without reaching for an aromatase inhibitor is to adjust your injection frequency. Splitting your weekly dose into more frequent smaller injections produces smaller peaks in testosterone and smaller peaks in the aromatization that follows. That one change alone resolves the estradiol issue for most men without any medication.

The third mechanism gets less attention because it doesn't show up on any blood panel.

Testosterone increases your total blood volume. Your body is now carrying more fluid than it was before you started. That alone asks more of your cardiovascular system. If your heart and vessels are well-adapted, they accommodate the increase. If they are not, that extra volume becomes extra pressure.

The adaptation comes from cardio. When you do sustained aerobic exercise consistently, your heart becomes more efficient at handling volume, your vessels become more compliant and better at expanding and contracting, and your resting blood pressure drops. Without that adaptation, you are adding load to a system that has no way to compensate.

This is not about being athletic. It's about giving your cardiovascular system the stimulus it needs to keep up with what TRT is asking of it.

Now here is what makes all of this worth understanding. When hematocrit is monitored and kept in range, when estradiol is managed through protocol rather than medication, and when cardio is consistent, TRT does not raise blood pressure long-term. A 2024 study tracking 737 men on testosterone therapy found that men not on blood pressure medication saw their systolic pressure drop by an average of 12.5 mmHg over the study period. In a separate cohort of 202 men who were already on antihypertensive medication, 33 of them were able to discontinue those medications entirely.

The mechanism there is that testosterone, when it's not driving erythrocytosis or fluid retention, improves lean body mass, reduces fat tissue, and improves insulin sensitivity, and all of those changes reduce the baseline drivers of hypertension.

The blood pressure problem and the blood pressure solution come from the same therapy. The difference is whether the three mechanisms are being tracked and managed or ignored.

---

References

1. Olesen TB, Glintborg D, Johnk F, et al. 2024. Blood pressure responses to testosterone therapy are amplified by hematocrit levels in opioid-induced androgen deficiency. Journal of Hypertension, 423, 531-540. Finding: Office SBP increased 6.2 mmHg in testosterone group vs 7.0 mmHg decrease in placebo net 13.2 mmHg. Men with hematocrit rise >6% saw clinically relevant BP increases. Source
2. Coviello AD, Kaplan B, Lakshman KM, et al. 2008. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. Journal of Clinical Endocrinology and Metabolism, 933, 914-919. Finding: Hemoglobin and hematocrit increased in a linear, dose-dependent fashion. Source
3. Almutlaq RN, Newell-Fugate AE, Evans LC, et al. 2022. Aromatase inhibition increases blood pressure and markers of renal injury in female rats. American Journal of Physiology Renal Physiology, 3232, F170-F181. Finding: Blocking aromatase increased mean arterial pressure. Source
4. Hackett G, Mann A, Haider A, et al. 2024. Testosterone replacement therapy: effects on blood pressure in hypogonadal men. World Journal of Mens Health, 422, 431-443. Finding: Long-term TRT associated with significant SBP and DBP reductions. 33 of 202 men on antihypertensives discontinued them. Source
5. Agrawal P, Singh SM, Kohn T. 2023. Management of erythrocytosis in men receiving testosterone therapy. European Urology Focus, 91, 139-142. Finding: Hematocrit >54% requires dose decrease or discontinuation. Source
6. Johannsson G, Gibney J, Wolthers T, et al. 2005. Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men. Journal of Clinical Endocrinology and Metabolism, 907, 3891-3896. Finding: Testosterone independently increased extracellular water through renal tubule effects. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness